Dinaciclib (SCH727965) (C09-0835-587)

Aladdin

Catalog No.: C09-0835-587
Manufacturer No.: D127362-100mg
Manufacturer Name: Aladdin Scientific
Quantity: 1
Unit of Measure: EA

Price: $783.48

List Price: $870.53

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account.

Current Stock:

Quantity:

Adding to cart… The item has been added

Description
Specifications

Dinaciclib (SCH727965) is a novel and potent CDK inhibitor for CDK2, CDK5, CDK1 and CDK9 with IC50 of 1 nM, 1 nM, 3 nM and 4 nM in cell-free assays, respectively. It also blocks thymidine (dThd) DNA incorporation.A novel and potent cyclin-dependent kinase inhibitor for Cdk2, Cdk5, Cdk1, and Cdk9. Specification: ≥98% Molecular Formula: C21H28N6O2 Molecular Weight: 396.49 PubChem CID: 46926350 Isomeric SMILES: CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCC[C@H]4CCO Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/D127362-SCI_f67b11328bc57644b1e8e039460c34f7.pdf

UPC:: 12352211
Condition:: New
Availability:: 2 weeks
Weight:: 0.97 Ounces
HazmatClass:: No
WeightUOM:: LB
MPN:: D127362-100mg
CAS:: 779353-01-4
Product Size:: 100mg
Hazard Statement Codes:: H315:H319:H340
Precautionary Statement Codes:: P260:P264:P270:P280:P281:P302+P352:P305+P351+P338:P362+P364:P405:P501

Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."